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Division of Geriatric and Palliative Care Medicine, University of Michigan, Ann Arbor, Michigan, USAa; Division of Infectious Diseases, Henry Ford Health System, Detroit,
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We readwith great interest the article by Senn andothers (1) asa prime example of how detailed molecular analysis can
unravel the epidemiological patterns that methicillin-resistant
Staphylococcus aureus (MRSA) strains follow in the colonizing
process and the usefulness of extranasal sampling to uncover
MRSA prevalence and spreading pathways.
Screening of MRSA on multiple body sites is well known to
greatly enhance isolation sensitivity. However, the study by Senn
et al. is among the first to open a new awareness about qualitative
differences in the behavior of specificMRSA strains. Based on our
experience, we concur with the implied author’s conclusion that
screening protocols limited to the nares may lead to selective under-
or overestimation of the prevalence of specific strains, with the po-
tential of greatly undermining surveillance efforts.As in Senn’s study,
our data also paint a picture of variability in strain behavior, which in
our case manifests itself in the response to interventions.
We performed molecular typing of 471 confirmed MRSA
strains isolated during our targeted infection prevention (TIP)
clinical trial (2), which focused on high-risk nursing home resi-
dents with an indwelling urinary catheter or feeding tube. The
intervention program included use of preemptive barrier precau-
tions, deidentified feedback, an interactive handhygiene program,
and an interactive infection prevention educational program for
all health care workers (3). Strains were assigned to 1 of 18 groups
based on SmaI pulsed-field gel electrophoresis (PFGE), Panton-
Valentine leukocidin (PVL) cytotoxin PCR (4), agr typing (5–7),
or SCCmec typing (8–10) and were stratified by site of isolation
(nasal, oral, groin, perianal, feeding tube insertion site, urinary
catheter insertion site, and wound). We observed significant
changes in the ratio of nasal to extranasal colonization in the in-
tervention facilities compared to the control facilities, among spe-
cific molecular types (Table 1). The ratio of nasal to extranasal
sample positivity was fairly consistent among different molecular
types in the control group. In the intervention group, however, the
ratiowas significantly decreased for some strains and increased for
others. In the absence of molecular typing, those changes would
have been unnoticed.Moreover, the total number of isolates from
all sites also showed different reduction percentages with the in-
tervention: type 2 isolates, for example, decreased by 65%, and
type 3 did not decrease at all. Type 2 isolates represent PFGE
USA300 PVL strains, which are commonly community ac-
quired. Most USA300 isolates described so far have been recov-
ered from wounds and skin and soft tissue infections, where they
can be the predominant type (11). However, in nursing homes,
USA300 isolates have been uncommon until recently (12). As in
Senn and colleagues’ observations, differential behavior of se-
lected strains was inferred from screening extranasal sites andmo-
lecular typing. In our case, this phenomenon manifested as a dif-
ferent response to interventions. This observation has few
precedents in the literature, except for specific resistance to topical
antiseptics (13, 14).
During the 3-year study period, we did not observe outbreaks in
any of the 12 facilities. This study, conducted in the nursing home
setting, adds confirmation that MRSA strain-specific characteristics
influences anatomic site colonization patterns and the response to
interventions. This must be taken into account when designing
resource-intensive interventions aimed at decreasingMRSA burden.
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TABLE 1 Distribution of the most represented MRSA types (20 or more isolates) for nasal versus extranasal colonization in control and
intervention facilities
Typea PFGE profile
No. of control isolates (3,258 swabs tested) No. of isolates with intervention (3,149 swabs tested)
Site of isolation
Total
Extranasal/nasal
ratio
Site of isolation
Total
Extranasal/nasal
ratioNasal Extranasal Nasal Extranasal
1 USA100 36 96 132 2.7 35 59 94b 1.7b
2 USA300 PVL 16 29 45 1.8 1 15 16b 15b
3 USA non-100-1100 16 29 45 1.8 8 41 49 5.1b
All 88 182 270 2.1 57 144 201b 2.5
a Type grouping was assigned based on 18 unique combinations of PFGE (1% tolerance), agr typing, SCCmec typing, or PVL typing.
b P values of0.05 (intervention vs. control).
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